文献速递白血病淋巴瘤

侵袭性NK细胞白血病合并单克隆B淋巴细胞增多症及噬血细胞综合征一例并文献复习

[Aggressive NK-cell leukemia with CD5(+)CD10(-) monoclonal B cell lymphocytosis and hemophagocytic lymphohistiocytosis: a case report and literature review].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2026-01-01

本文报道1例73岁男性侵袭性NK细胞白血病(ANKL)患者,同时合并CD5(+)CD10(-)单克隆B淋巴细胞增多症及噬血细胞性淋巴组织细胞增生症(HLH)。骨髓形态学及活检发现两群异常细胞,经流式细胞术、免疫组化及基因检测确诊。早期予依托泊苷联合地塞米松,后接受培门冬酶为基础方案化疗3个疗程后病情恶化,死于多器官功能衰竭。

要点

  • ANKL可同时合并单克隆B淋巴细胞增多症及HLH,诊断需综合形态学、流式、免疫组化及基因检测。
  • 骨髓中可存在两群形态不同的异常细胞,提示需警惕双重克隆性疾病。
  • 本例早期予依托泊苷联合地塞米松,后以培门冬酶为基础方案化疗3疗程,病情仍恶化。

核心结论

  • ANKL罕见且进展迅速、致死率高,可同时合并CD5(+)CD10(-)单克隆B淋巴细胞增多症及HLH。
  • 本例患者虽经依托泊苷联合地塞米松及培门冬酶为基础方案化疗,仍因多器官功能衰竭死亡。

研究设计与样本

  • 个案报道并复习相关文献:1例73岁男性患者,因不明原因发热伴多部位淋巴结肿大持续1个多月就诊。

主要发现

  • 骨髓细胞形态学及骨髓活检发现两群形态不同的异常细胞。
  • 流式细胞术、免疫组化及基因检测符合ANKL合并CD5(+)CD10(-)单克隆B淋巴细胞增多症特征,同时继发HLH。
  • 早期予依托泊苷联合地塞米松治疗,后接受培门冬酶为基础联合方案化疗3个疗程后病情恶化。
  • 患者因多器官功能衰竭抢救治疗无效死亡。

临床怎么用

  • 对ANKL疑似病例应完善骨髓形态、活检、流式细胞术、免疫组化及基因检测以识别合并症。
  • 合并单克隆B淋巴细胞增多症及HLH时需综合诊断,治疗可参考依托泊苷联合地塞米松及培门冬酶为基础方案。

局限性

  • 本文为单例个案报道,结论外推受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aggressive natural killer (NK) -cell leukemia (ANKL) is a rare hematological malignancy characterized by the abnormal proliferation of NK cells. It progresses rapidly and has a high mortality rate. This article reports the diagnosis and treatment of a rare case of a patient with ANKL and concurrent CD5(+)CD10(-) monoclonal B-cell lymphocytosis and hemophagocytic lymphohistiocytosis (HLH), and the relevant literature was reviewed. The patient was a 73-year-old male who presented with fever and lymphadenopathy in multiple areas without any obvious cause for over 1 month. Laboratory examinations, including bone marrow cell morphology and biopsy, revealed two distinct populations of abnormal cells. Flow cytometry, immunohistochemical staining, and gene testing confirmed the diagnoses of ANKL and CD5(+)CD10(-) monoclonal B-cell lymphocytosis, with concurrent HLH. The patient was initially treated with etoposide and dexamethasone. After receiving three courses of chemotherapy based on pegaspargase and other combination regimens, the patient's condition deteriorated. Resuscitation treatment was ineffective; the patient died due to multiple organ failure. 侵袭性NK细胞白血病(ANKL)是一种以NK细胞异常增生为特征的罕见血液系统恶性肿瘤,其病情进展迅速且致死率高。本文报道1例罕见的同时合并CD5(+)CD10(-)单克隆B淋巴细胞增多症及噬血细胞性淋巴组织细胞增生症(HLH)的ANKL患者诊治过程并进行相关文献复习。患者为73岁男性,无明显诱因发热伴多部位淋巴结肿大持续1个多月。实验室检查骨髓细胞形态学及骨髓活检发现两群形态不同的异常细胞,经流式细胞术、免疫组化及基因检测符合ANKL合并CD5(+)CD10(-)单克隆B淋巴细胞增多症特征,同时继发HLH。早期给予依托泊苷联合地塞米松治疗,患者在接受培门冬酶为基础联合方案化疗3个疗程后,病情恶化,因多器官功能衰竭抢救治疗无效死亡。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liu M, Liu XJ, Zhou Y, et al. [Aggressive NK-cell leukemia with CD5(+)CD10(-) monoclonal B cell lymphocytosis and hemophagocytic lymphohistiocytosis: a case report and literature review]. Zhonghua Xue Ye Xue Za Zhi. 2026. PMID: 42161665. doi:10.3760/cma.j.cn121090-20250920-00429

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。